

Lentivirus and AAV Transfection Reagent Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The Lentivirus and AAV Transfection Reagent market is experiencing steady growth due to the increasing demand for gene therapy and genetic research applications. The market size is estimated to reach $XX billion by 2025, driven by advancements in technology and the rise in genetic disorders worldwide. Request
◍ Mirus Bio
◍ Thermo Fisher Scientific
◍ Polyplus-transfection
◍ Takara Bio
◍ GeneMedi
◍ SignaGen Laboratories
◍ Roche
◍ Invitrogen
◍ System Bioscience
◍ WZ Biosciences
◍ Inovogen Tech
The Lentivirus and AAV Transfection Reagent Market is highly competitive with companies like Mirus Bio, Thermo Fisher Scientific, Polyplus-transfection, Takara Bio, GeneMedi, SignaGen Laboratories, Roche, Invitrogen, System Bioscience, WZ Biosciences, and Inovogen Tech dominating the market. These companies offer a wide range of transfection reagents to customers, enabling efficient gene delivery for research and therapeutic applications.
- Mirus Bio reported sales revenue of $10 million in 2020.
- Thermo Fisher Scientific reported sales revenue of $8.6 billion in 2020.
- Takara Bio reported sales revenue of $1.5 billion in 2020.
By Application
◍ Laboratory
◍ Hospital
By Product
◍ AAV
◍ Lentivirus
◍ Complex
Request Sample Report